Horizon sets up shop in Bay Area at it ramps up R&D, manufacturing

SourceFierce Biotech
Date Published11/22/2019
Author NameAmirah Al Idrus
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Horizon Therapeutics
Parent companyHorizon Therapeutics
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2019
Country(ies) from which reshored:Ireland
City reshored to:San Francisco
State(s) reshored to:CA
If relevant, work nearshored to:-
Product(s) reshoredmedicines
What domestic positive factors made reshoring more attractive?Eco-system synergies, Lead time/Time to market, Manufacturing/engineering joint innovation (R&D)
Find Reshoring Articles